Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,048 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 660 | $68.51 | $45,216.60 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,420 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,080 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:15 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057395 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238 Underlying: Common Stock · 238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 238 shares vested on December 1, 2023; the remaining 238 shares will vest on December 1, 2024. F4 · derivative.expiration_date: 238 shares vested on December 1, 2023; the remaining 238 shares will vest on December 1, 2024. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:15 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 119 | $69.22 | $8,237.18 |
DisclosureSEC source: 0001209191-23-057395 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,470 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:15 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057395 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,589 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| November 28, 2023 Filed Feb 2, 2024 20:08 UTC |
Prutow JamesDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 1,519 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010875 · ownership.xml · derivative · entry 1 Prutow James · CIK 0002003827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,519 Underlying: Common Stock · 1,519 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 28, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 28, 2024. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 16:15 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054981 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,970 Underlying: Common Stock · 3,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,970 shares vested on November 8, 2023; the remaining 3,970 shares will vest on November 8, 2024. F4 · derivative.expiration_date: 3,970 shares vested on November 8, 2023; the remaining 3,970 shares will vest on November 8, 2024. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 16:15 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 1,449 | $60.29 | $87,360.21 |
DisclosureSEC source: 0001209191-23-054981 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,351 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 16:15 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054981 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052948 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 780 Underlying: Common Stock · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. F4 · derivative.expiration_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 194 | $68.02 | $13,195.88 |
DisclosureSEC source: 0001209191-23-052948 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,466 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052948 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,660 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052949 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 780 Underlying: Common Stock · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. F4 · derivative.expiration_date: 390 shares vested on October 15, 2023; the remaining 780 shares will vest in equal installments on October 15, 2024 and October 15, 2025. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 135 | $68.02 | $9,182.70 |
DisclosureSEC source: 0001209191-23-052949 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,830 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:10 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052949 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,965 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 17:45 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049795 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314 Underlying: Common Stock · 314 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 314 shares vested on September 14, 2023; the remaining 314 shares will vest on September 14, 2024. F4 · derivative.expiration_date: 314 shares vested on September 14, 2023; the remaining 314 shares will vest on September 14, 2024. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 17:45 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 156 | $76.37 | $11,913.72 |
DisclosureSEC source: 0001209191-23-049795 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,270 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 17:45 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049795 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,426 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 16:05 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-047501 · doc4.xml · derivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,461 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,461 shares vested on August 24, 2023. F5 · derivative.expiration_date: 1,461 shares vested on August 24, 2023. Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 16:05 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 725 | $78.33 | $56,789.25 |
DisclosureSEC source: 0001209191-23-047501 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 535,570 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 16:05 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 1,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-047501 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,295 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 291 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 16:05 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043942 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,170 Underlying: Common Stock · 1,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,170 shares vested on July 28, 2023; 1,170 shares will vest on July 28, 2024. F5 · derivative.expiration_date: 1,170 shares vested on July 28, 2023; 1,170 shares will vest on July 28, 2024. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 16:05 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 549 | $87.12 | $47,828.88 |
DisclosureSEC source: 0001209191-23-043942 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,639 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 16:05 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043942 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,188 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction include an additional 218 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 16:05 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040962 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 981 shares vested on July 1, 2023. F4 · derivative.expiration_date: 981 shares vested on July 1, 2023. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 16:05 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 436 | $82.86 | $36,126.96 |
DisclosureSEC source: 0001209191-23-040962 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,800 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 16:05 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040962 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,236 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:31 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035427 · doc4.xml · derivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:31 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035427 · doc4.xml · nonDerivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,297 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:29 UTC |
Smith Christopher MDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035401 · doc4.xml · derivative · entry 3 Smith Christopher M · CIK 0001436707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:29 UTC |
Smith Christopher MDirector
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035401 · doc4.xml · nonDerivative · entry 1 Smith Christopher M · CIK 0001436707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,249 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:20 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035387 · doc4.xml · derivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:20 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035387 · doc4.xml · nonDerivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,638 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:22 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035391 · doc4.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:22 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035391 · doc4.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,685 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:23 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035394 · doc4.xml · derivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:23 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035394 · doc4.xml · nonDerivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,496 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:31 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035426 · doc4.xml · derivative · entry 4 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F5 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:31 UTC |
Strobeck MatthewDirector
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035426 · doc4.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,430 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:20 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035388 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:20 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035388 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,797 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:21 UTC |
Michael Edward L.Director
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035389 · doc4.xml · derivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:21 UTC |
Michael Edward L.Director
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035389 · doc4.xml · nonDerivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,824 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:32 UTC |
Wilkins Joseph D Jr.Director
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035430 · doc4.xml · derivative · entry 2 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:32 UTC |
Wilkins Joseph D Jr.Director
|
GrantCommon Stock | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035430 · doc4.xml · nonDerivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,161 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC |
Busky Joseph M.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034578 · doc4.xml · derivative · entry 3 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,565 Underlying: Common Stock · 5,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 5,391 shares vested on June 1, 2023, 5,391 shares will vest on June 1, 2024 and 5,392 shares will vest on June 1, 2025. F5 · derivative.expiration_date: 5,391 shares vested on June 1, 2023, 5,391 shares will vest on June 1, 2024 and 5,392 shares will vest on June 1, 2025. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC |
Busky Joseph M.Chief Financial Officer
|
Tax withholdingCommon Stock | 1,637 | $85.65 | $140,209.05 |
DisclosureSEC source: 0001209191-23-034578 · doc4.xml · nonDerivative · entry 2 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,946 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantCommon Stock | 5,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034578 · doc4.xml · nonDerivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,583 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 192 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC |
Iskra Michael S.EVP & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034579 · doc4.xml · derivative · entry 3 Iskra Michael S. · CIK 0001839432 · EVP & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,188 Underlying: Common Stock · 3,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,594 shares vested on June 1, 2023; the remaining 7,188 shares will vest in equal installments on June 1, 2024 and June 1, 2025. F4 · derivative.expiration_date: 3,594 shares vested on June 1, 2023; the remaining 7,188 shares will vest in equal installments on June 1, 2024 and June 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.